post operative analgesic effect of infiltration of bupivacaine and dexmedetomidine in surgical wound- A randomised placebo controlled trial

A total of ninety patients will be enrolled, those aged between 15 - 60 years; of ASA status 1 and 2 and undergoing elective abdominal surgeries. They will be randomised into three groups; receiving placebo, bupivacaine (25 ml of 0.25%) and dexmedetomidine (1 mcg/kg dexmedetomidine added to 25 ml of 0.25% bupivacaine) at the end of surgery. pain at rest and on cough will be assessed up to 24 hours after surgery. rescue analgesia will be given with i.v. tramadol 1.5 mg/kg. number of patients requiring rescue analgesia and total consumption of tramadol will be recorded. level of sedation will be assessed using 4 point sedation scale. any adverse effects like nausea/vomiting, hypotension, bradycardia, dry mouth, dizziness, diplopia will be recorded.